Dante Labs announces expansion of its Whole Genome Sequencing test with enhanced and broader offeringNEW YORK, March 03, 2022 (GLOBE NEWSWIRE) Dante Labs, a global leader in genomics and precision medicine, today announced the expansion of its Dante 30X Whole Genome Sequencing Test with personalized interpretatio.
NEW YORK, Feb. 23, 2022, a global leader in genomics and precision medicine, is pleased to announce that the company has been selected as a genetic services provider for Abu Dhabi Executive Office (ADEO)
NEW YORK, Feb. 18, 2022, a global leader in genomics and precision medicine, today announced it has partnered with The Renato Dulbecco Foundation to deliver more personalized therapies in rare diseases